English | Spanish
ecancer
Login Register
The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [129]
News [229]
Articles [14]
Editorials [3]
Conferences [41]
elearning [17]
COVID-19 and cancer: Useful resources
COVID-19 and cancer: Useful resources
Researchers identify a novel player in acute myeloid leukaemia
Researchers identify a novel player in acute myeloid leukaemia
Immunotherapy after high-dose chemotherapy leads to favorable outcomes in acute myeloid leukaemia
Immunotherapy after high-dose chemotherapy leads to favorable outcomes in acute myeloid leukaemia
Anti-androgen therapy can fuel spread of bone tumours in advanced prostate cancer
Anti-androgen therapy can fuel spread of bone tumours in advanced prostate cancer
SFRP2 and PD-1 immunotherapy combination halts osteosarcoma metastasis in model
SFRP2 and PD-1 immunotherapy combination halts osteosarcoma metastasis in model
EHA 2021: ALPINE study reveals superior safety and efficacy of zanubrutinib compared with ibrutinib
EHA 2021: ALPINE study reveals superior safety and efficacy of zanubrutinib compared with ibrutinib
Researchers discover gene linked to bone cancer in children and identify potential novel therapy
Researchers discover gene linked to bone cancer in children and identify potential novel therapy
New insight into when CAR T is effective against childhood leukaemia
New insight into when CAR T is effective against childhood leukaemia
Aged bone marrow niche impedes function of rejuvenated haematopoietic stem cells
Aged bone marrow niche impedes function of rejuvenated haematopoietic stem cells
Cancer trial participation does not eliminate disparities for poor patients
Cancer trial participation does not eliminate disparities for poor patients
<12345...23>

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2022 ecancer, all rights reserved
UK registered charity number: 1176307